
FTSE 100 edges up as AstraZeneca falls on merger talks; Shell sells renewables unit amid oil price drop.
The FTSE 100 rose slightly to 10,888 points despite AstraZeneca shares dropping 7% due to merger talks with Bristol Myers Squibb, which face regulatory scrutiny. Shell agreed to sell its European onshore renewables business to TotalEnergies, reflecti...

